What’s New in Diagnostic Technologies for People Living with Blood Cancers

Peter Martin, MD, MS

Chief Lymphoma Program, Associate Professor of Medicine, Weill Cornell Medicine, Associate Attending Physician, NewYork-Presbyterian Hospital

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

Ruben A. Mesa, MD, FACP

Executive Director, Mays Cancer Center at UT Health San Antonio MD Anderson, Mays Family Foundation Distinguished University Presidential Chair, Professor of Medicine, Mays Cancer Center – An NCI Designated Cancer Center

Matthew J. Butler, MD

Assistant Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, Mays MD Anderson Cancer Center, UT Health San Antonio

Joseph Khoury, MD, FCAP

Professor, Division of Pathology & Lab Medicine, Department of Hematopathology, Medical Director, Clinical Expansion, Division of Pathology & Lab Medicine, Executive Director, MD Anderson Cancer Network, Division of Pathology & Lab Medicine, The University of Texas M. D. Anderson Cancer Center

Sarah Thibault-Sennett, PhD

Senior Manager, Public Policy & Advocacy, Association for Molecular Pathology (AMP)

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare